Healthcare Blogs

  Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major branded insulin products start to expire, several biosimilar insulin markets are expected to launch in the coming years. Insulin Biosimilars Market was valued at USD 2311 Million in 2019 and is expected to register a CAGR of14.80% during the forecast period of 2022 to 2030. The USFDA approved new insulin glargine Basilar, for type 1 and type 2 diabetes which is a biosimilar version of Sanofi’s basal insulin Lantus (insulin glargine). Additionally, Lilly and Boehringer Ingelheim’s biosimilar insulin glargine has got approval through the European Medicines Agency’s (EMA’s) Biosimilar pathway. Such o

  Botulinum Toxin Market Highlights The botulinum toxin market size is projected to reach USD 6.5 billion by 2030, at a CAGR of 11.80% from 2022 to 2030. Botulinum toxin is known as one of the most poisonous biological substances. It is a neurotoxin produced by the bacterium Clostridium botulinum. There are seven distinct forms of botulinum toxin, types A–G. Four of these (types A, B, E, and rarely F) cause human botulism. Botulinum toxin A and B are used for therapeutic and aesthetic procedures. The increasing cases of spasticity, cervical dystonia and chronic migraine, surge in demand for facial aesthetic, and rising number of product launches and approvals by key players are likely to drive the growth of the global botulinum toxin market during the forecast period. Segment Analysis The Global Botulinum Toxin Market, by type, has been segmented into botulinum toxin type A and B.   Rising adoption of botulinum toxin in aesthetic procedures as compared to tissue fillers and in

  Global Cataract Surgery Device Market Scenario: Cataract Surgery Devices Market Size was valued at USD 8.6 billion in 2022 and is projected to grow from USD 9.1 Billion in 2023 to USD 12.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.19% during the forecast period (2022 - 2030).   The global visual impairment population is increasing gradually which is the primary driving force behind the growth of the global cataract surgery device market. Increasing prevalence of eye disorders, especially cataract which necessitates surgery and, in turn, drives the market for cataract surgery device market. The gradual rise in global geriatric population is also estimated to be a positive driving force for market growth. The aging populace is more prone to developing cataract, and the demographic shift in developed countries towards older age will lead to an increased rate of cataract surgeries. The economic upsurge in developing countries has directed the gove

  Population Health Management Market Overview The Population health management market Size was valued at USD 68.4 billion in 2021 and is projected to grow from USD 81.5 billion in 2022 to USD 278.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 19.20% during the forecast period (2022 - 2030). The report outlines the strengths, opportunities, threats, and potential business risks and provides a comprehensive analysis of the global market situation with the impact of COVID-19. Population health management market is a collection and review of patient data from a range of information technology resources. Population health management aims to track the status of the patient and identify disease-based patients. This also aims to improve clinical outcomes and reduce the cost of treatment. Market Dynamics The growing prevalence of chronic diseases that require constant monitoring and treatment, the adoption of IT healthcare, and increased government funding are

  Internet of Things in Healthcare Market Highlights According to MRFR analysis, the Internet of Things (IOT) in healthcare market is expected to cross USD 632.53 billion by 2030 at a CAGR of ~25.50%. The global IoT in healthcare market is driven by several factors, such as increasing adoption of wearables to measure vitals regularly, rising mental and physical health awareness among the young population, growing telemedicine sector, and rising demand for remote monitoring systems. In addition, the emergence of implantable monitoring systems, ingestible sensors, and connected smart contact lenses is also creating new opportunities for the market. These monitoring and tracking systems analyse the vitals and notify the patient of the next drug dose. Moreover, the introduction of smart hospitals across the globe is generating possibilities for the deployment of IoT-based devices. This will enable medical staff to accelerate the processing of patient data, better drug and medicine man

  Behavioral Health Services Market Highlights Behaviour health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders. insights Behavioral health includes conditions such as depression, anxiety, substance abuse, and others. Around 83% people in the US are suffering from Behavioral health issues. According to Japanese study around 298 people were suffering from various Behavioral disorders in 2018. The growth of the global Behavioral health services market is driven by various factors such as an increasing global geriatric population, rising prevalence of the depressive disorder, and poor fitness levels. However, high costs of treatment are expected to curb the growth of the global Behavioral health services market. According to MRFR analysis,  Behavioral Health Services Market  is expected to register a CAGR of 5.12% during the forecast period of 2022 to 2030 and was valued at USD 214.0 billion by 2030. The Glob

  Bone Graft Substitutes Market Synopsis: Market Research Future (MRFR)’s latest study reveals that the Bone Graft Substitute Market is projected to reach USD 2,121.66 million by 2030 at 6.80% CAGR during the forecast period 2022-2030. The increasing prevalence of diseases related to bones has intensified the demand for bone graft substitutes. Additionally, the rising awareness about the developments in bone graft substitutes coupled with rising healthcare expenditure is likely to augment the market size and revenue over the next couple of years. The painful procedure related to autografts have paved the way for developments in the bone graft substitutes market. Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise. It is projected to aid the proliferation of the market in the forthcoming years by accelerating its adoption. The growth of the bone graft substitutes market is guided by the factors such as increasing ortho